Captrust Financial Advisors lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 164,324 shares of the healthcare conglomerate's stock after selling 46,140 shares during the quarter. Captrust Financial Advisors' holdings in UnitedHealth Group were worth $83,125,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
UNH has been the topic of a number of research reports. Mizuho boosted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Barclays reduced their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a report on Monday, April 21st. HSBC reiterated a "hold" rating and issued a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $596.86.
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Price Performance
Shares of NYSE:UNH traded down $9.60 during trading on Tuesday, reaching $395.21. The company had a trading volume of 7,831,081 shares, compared to its average volume of 4,648,576. UnitedHealth Group Incorporated has a 12 month low of $393.11 and a 12 month high of $630.73. The company has a fifty day moving average of $493.20 and a two-hundred day moving average of $526.12. The stock has a market capitalization of $359.73 billion, a P/E ratio of 25.50, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the company posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.